MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center
| dc.coverage | DOI: 10.1007/s00261-021-03212-7 | |
| dc.creator | Hernandez-Meza, Gabriela | |
| dc.creator | Violi, Naik Vietti | |
| dc.creator | Said, Daniela | |
| dc.creator | Novogrodsky, Eitan | |
| dc.creator | Villavisanis, Dillan | |
| dc.creator | Maron, Samuel Z. | |
| dc.creator | Frere, Justin | |
| dc.creator | Schiano, Thomas D. | |
| dc.creator | Friedman, Scott | |
| dc.creator | Boffetta, Paolo | |
| dc.creator | Branch, Andrea | |
| dc.creator | Taouli, Bachir | |
| dc.date | 2021 | |
| dc.date.accessioned | 2025-11-18T19:45:34Z | |
| dc.date.available | 2025-11-18T19:45:34Z | |
| dc.description | <p>Purpose: In this study, we describe the patterns of hepatocellular carcinoma (HCC) screening with imaging and factors associated with imaging modality selection in a tertiary care transplant center. Methods: This was a retrospective study where all adult patients with cirrhosis and/or chronic hepatitis B virus infection referred for HCC screening with ultrasound (US), CT or MRI were identified during 2017. The association between imaging methods, demographic/clinical data were analyzed by uni- and multivariate analysis. Results: A total of 1437 patients were included (median age 61y, 59% male, median BMI 27.5 kg/m<sup>2</sup>, median AFP 3.4 ng/mL, 37% with HCV and 87% with cirrhosis). Index screening imaging method utilization included MRI (51%), US (33%) and CT (16%). Use of US as the index imaging modality for screening was significantly associated with race/ethnicity [Odds Ratio (OR) 1.71–2.01, all p < 0.05] in multivariate analysis. Presence of cirrhosis (OR 0.29, p < 0.001) and referral by a hepatologist (OR 0.23, p < 0.001) were associated with screening with MRI in the multivariate analysis; while gender, age, BMI, etiology and income at ZIP code of residence were not significantly associated with imaging modality selection. HCC was observed in 62 patients (prevalence 4.3%). Rate of HCC detection was significantly higher with MRI vs US (5.9% vs. 1.5%, p = 0.001). Conclusion: MRI was the most frequently used modality (> 50%) for HCC screening in our tertiary care center, in contrast with the current practice guidelines. Race/ethnicity, cirrhosis and referral by a hepatologist were associated with the imaging method used for HCC screening.</p> | eng |
| dc.identifier | https://investigadores.uandes.cl/en/publications/4367b97a-5de7-4a59-ad39-7175e36303ac | |
| dc.identifier.uri | https://repositorio.uandes.cl/handle/uandes/54040 | |
| dc.language | eng | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | |
| dc.source | vol.46 (2021) nr.11 p.5142-5151 | |
| dc.subject | Hepatocellular carcinoma | |
| dc.subject | Magnetic Resonance Imaging | |
| dc.subject | Screening | |
| dc.subject | Ultrasonography | |
| dc.subject | SDG 3 - Good Health and Well-being | |
| dc.title | MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center | eng |
| dc.type | Article | eng |
| dc.type | Artículo | spa |